Eurointervention

Papers
(The H4-Index of Eurointervention is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
In search of the origin of the acronym TAVI258
TAVR under 70: is age just a number?141
International variation in modality and outcomes of left main revascularisation: does it really matter?117
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity113
Double-tap to treat paravalvular leak in high-risk annuli105
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study86
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis83
Transcatheter left ventriculoplasty76
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis66
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement59
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s58
Recanalisation of coronary chronic total occlusions53
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry51
Defer-based non-stenting: a promising approach for STEMI48
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure47
Hybrid coronary revascularisation: the best or the worst of both worlds?44
   Atrial fibrillation and acute coronary syndrome 43
The “road travelled”: reflections on the transformation of information exchange in a digital age43
One-month DAPT after acute coronary syndrome: too short or not too short?40
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve37
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study37
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document36
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection36
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation35
Redo transcatheter mitral valve replacement in mitral annular calcification35
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes34
Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis34
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study34
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial33
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study32
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD31
Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial31
0.25065207481384